Evidence map›Paper›PMID 20820497›Full record

ArticleThe Analyst2010

Capillary electrophoretic development of aptamers for a glycosylated VEGF peptide fragment.

Christopher M Rose, Michael J Hayes, Gregory R Stettler, Scott F Hickey, Trevor M Axelrod, Nicholas P Giustini, Steven W Suljak

Open access · greenAbstract read
In one paragraph

Article in The Analyst, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Christopher M RoseDepartment of Chemistry and Biochemistry, Santa Clara University, Santa Clara, CA, USA.
Michael J Hayes
Gregory R Stettler
Scott F Hickey
Trevor M Axelrod
Nicholas P Giustini
Steven W Suljak
Santa Clara University · US

Funding

Aptamers to distinguish functional modification of target proteins by affinity prR15GM081854 · NIGMS · SANTA CLARA UNIVERSITY · PI SULJAK, STEVEN WILLIAM · 2007 to 2009
$232k
NIGMS NIH HHS R15 GM081854NIGMS NIH HHS R15GM081854
6 · The paper itself

Abstract

The emergence of functional genomics and proteomics has added to the growing need for improved analysis methods that can detect and distinguish between protein variants resulting from allelic variation, mutation, or post-translational modification. Aptamers, single-stranded DNA or RNA molecules that fold into three-dimensional structures conducive to binding targets, have become an attractive alternative to antibodies for this type of analysis. Although aptamers have been developed for a wide range of target species, very few sequences have been identified that bind selectively to proteins with specific post-translational modifications. Using capillary electrophoresis-based selection, we have developed DNA aptamer sequences that selectively bind an N-glycosylated peptide fragment of vascular endothelial growth factor (VEGF). The selection method incorporates alternating positive- and counter-selection steps in free solution in order to obtain aptamers with both high affinity toward the glycosylated target and high selectivity versus a non-glycosylated variant. Affinity capillary electrophoresis and surface plasmon resonance binding assays indicate these sequences have low-µM dissociation constants and preferentially bind the glycosylated peptide with as much as 50-fold specificity. Such aptamers could serve as tools for rapid and simple monitoring of disease-linked functional changes in proteins, with potential applications in drug screening and disease diagnosis.

Indexed as

Aptamers, NucleotideBinding SitesElectrophoresis, CapillaryGlycosylationPeptide FragmentsSurface Plasmon ResonanceVascular Endothelial Growth FactorsAptamers, NucleotidePeptide FragmentsVascular Endothelial Growth Factors

Identifiers

PMID20820497
PMCPMC2957546
OpenAlexW2029109560

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.